Home / Drug shortages / Adalimumab-afzb Injection

Adalimumab-afzb Injection — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Adalimumab-afzb Injection (injection) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on 10/09/2025.

Shortage Details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0025-0325-01
Dosage Form
Injection
Presentation
Abrilada, Injection, Kit (NDC 0025-0325-01)
Initial Posting
10/09/2025
Revised Date

FDA data resources